Immunotherapy: changing the face of melanoma treatment | TRM CancerBRC
Scientific Advisory Board | Nanobiotix
Scientific Advisory Board – PsiVac
Professor Kevin Harrington - The Institute of Cancer Research, London
World-first centre for recurrent head & neck cancer - Professor Christopher Nutting Oncology
Kevin Harrington (@kevhar6763) / Twitter
Skin cancer: below the surface | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
GM herpes virus fights advanced cancers
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
Pablo NENCLARES | Research Fellow | Clinical Oncologist | Head and Neck Unit / Radiotherapy and Imaging Team | Research profile
Radiotherapy Theme on Vimeo
The Royal Marsden NHS Foundation Trust on Twitter: "Huge congratulations Professors David Cunningham, Johann De Bono, Kevin Harrington, Nicholas Turner, Mitch Dowsett, James Larkin! #HighlyCited2021" / Twitter
PATRIOT: ATR inhibitor monotherapy in advanced solid tumors | VJOncology
SAB and I-O AB - T3 Pharma
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington - The Institute of Cancer Research, London
Cancer: Scientists aim to double survival within a decade | The Independent
